News

Eli Lilly and Company is in advanced discussions to acquire Kelonia Therapeutics for more than $2 billion, according to a report by The Wall Street Journal. The report, citing people familiar with the matter, indicates that a deal could...

The U.S. Food and Drug Administration is preparing to revisit its stance on a group of peptide substances, as its Pharmacy Compounding Advisory Committee schedules a summer meeting that could influence how these products are regulated. The FDA advisory...

Smart packaging reflects key trends in the pharmaceutical industry and is reshaping how you deliver value across the product life cycle. While regulatory mandates accelerated adoption, they represent only the starting point. You now operate in an environment that...

A new integrated approach to long-read sequencing of archived tissue samples has been introduced through a collaboration between PacBio and Covaris, with the workflow set to be presented at the American Association for Cancer Research Annual Meeting. The jointly...

Strategies that address tissue hypoxia and metabolic dysfunction at a cellular level are increasingly shaping neuropathy treatment. Among these, hyperbaric oxygen therapy nerve regeneration has emerged as a focal point for pharmaceutical innovation. As industry stakeholders seek scalable, mechanism-driven...

Ergonomics should be a top priority for any organization undergoing digital transformation in the pharmaceutical industry. Integrating mobile health into your operations can revolutionize patient recruitment and retention in clinical trials, medication adherence, real-time data collection and monitoring, and...

The U.S. Food and Drug Administration has released a draft guidance outlining safety assessment standards for human gene therapy products that incorporate genome editing technologies, marking a step toward streamlining development pathways for advanced therapies. Announced on April 14,...